Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 383

1.

Letter by Müller et al Regarding Article, "Left Atrial Volume Index Is Associated With Cardioembolic Stroke and Atrial Fibrillation Detection After Embolic Stroke of Undetermined Source".

Müller P, Akoum N, Eckardt L.

Stroke. 2019 Aug 14:STROKEAHA119026818. doi: 10.1161/STROKEAHA.119.026818. [Epub ahead of print] No abstract available.

PMID:
31409265
2.

[Atrial fibrillation in patients with sepsis and non-cardiac infections].

Rath B, Niehues P, Leitz P, Eckardt L.

Herzschrittmacherther Elektrophysiol. 2019 Aug 8. doi: 10.1007/s00399-019-0633-z. [Epub ahead of print] Review. German.

PMID:
31396698
3.

Determinants of inappropriate implantable cardioverter-defibrillator shocks: the German Device Registry perspective.

Safak E, Eckardt L, Jung W, Ince H, Senges J, Hochadel M, Perings C, Spitzer S, Brachmann J, Seidl K, Hink HU, D'Ancona G.

J Interv Card Electrophysiol. 2019 Aug 2. doi: 10.1007/s10840-019-00600-4. [Epub ahead of print]

PMID:
31375974
4.

Implantable cardioverter defibrillators in patients with electrical heart disease and hypertrophic cardiomyopathy: data from the German device registry.

Frommeyer G, Reinke F, Andresen D, Kleemann T, Spitzer SG, Jehle J, Brachmann J, Stellbrink C, Hochadel M, Senges J, Eckardt L.

Clin Res Cardiol. 2019 Jul 31. doi: 10.1007/s00392-019-01532-9. [Epub ahead of print]

PMID:
31367999
5.

[Cardiac arrhythmias in patients with chronic kidney disease].

Niehues P, Ellermann C, Eckardt KU, Eckardt L.

Herzschrittmacherther Elektrophysiol. 2019 Jul 23. doi: 10.1007/s00399-019-0631-1. [Epub ahead of print] Review. German.

PMID:
31338579
6.

Proarrhythmic Effect of Acetylcholine-Esterase Inhibitors Used in the Treatment of Alzheimer's Disease: Benefit of Rivastigmine in an Experimental Whole-Heart Model.

Ellermann C, Coenen A, Niehues P, Leitz P, Kochhäuser S, Dechering DG, Fehr M, Eckardt L, Frommeyer G.

Cardiovasc Toxicol. 2019 Jul 13. doi: 10.1007/s12012-019-09543-8. [Epub ahead of print]

PMID:
31302839
7.

The entirely subcutaneous ICDTM system in patients with congenital heart disease: experience from a large single-centre analysis.

Willy K, Reinke F, Bögeholz N, Köbe J, Eckardt L, Frommeyer G.

Europace. 2019 Jul 13. pii: euz190. doi: 10.1093/europace/euz190. [Epub ahead of print]

PMID:
31302706
8.

Candida tropicalis defibrillator endocarditis: A case report and review of current literature.

Bauer BK, Schulze AB, Löher A, Reinke F, Eckardt L.

Med Mycol Case Rep. 2019 Jun 8;25:1-9. doi: 10.1016/j.mmcr.2019.06.001. eCollection 2019 Sep.

9.

Action Potential Triangulation Explains Acute Proarrhythmic Effect of Aliskiren in a Whole-Heart Model of Atrial Fibrillation.

Ellermann C, Mittelstedt A, Wolfes J, Willy K, Leitz P, Reinke F, Eckardt L, Frommeyer G.

Cardiovasc Toxicol. 2019 Jun 7. doi: 10.1007/s12012-019-09533-w. [Epub ahead of print]

PMID:
31175534
10.

Time-to-isolation-guided cryoballoon ablation reduces oesophageal and mediastinal alterations detected by endoscopic ultrasound: results of the MADE-PVI trial.

Cordes F, Ellermann C, Dechering DG, Frommeyer G, Kochhäuser S, Lange PS, Pott C, Lenze F, Schmidt H, Ullerich H, Eckardt L.

Europace. 2019 May 29. pii: euz142. doi: 10.1093/europace/euz142. [Epub ahead of print]

PMID:
31143952
11.

Reply to letter to the editor by Gulmira Kudaibedieva and Bulent Gorenek.

Frommeyer G, Reinke F, Eckardt L.

Clin Res Cardiol. 2019 Aug;108(8):968. doi: 10.1007/s00392-019-01460-8. Epub 2019 May 2. No abstract available.

PMID:
31049681
12.

Procedural success, safety and patients satisfaction after second ablation of atrial fibrillation in the elderly: results from the German Ablation Registry.

Fink T, Metzner A, Willems S, Eckardt L, Ince H, Brachmann J, Spitzer SG, Deneke T, Schmitt C, Hochadel M, Senges J, Rillig A.

Clin Res Cardiol. 2019 Apr 5. doi: 10.1007/s00392-019-01471-5. [Epub ahead of print]

PMID:
30953179
13.

Feasibility of entirely subcutaneous ICD™ systems in patients with coronary artery disease.

Willy K, Bettin M, Reinke F, Bögeholz N, Ellermann C, Rath B, Leitz P, Köbe J, Eckardt L, Frommeyer G.

Clin Res Cardiol. 2019 Mar 21. doi: 10.1007/s00392-019-01455-5. [Epub ahead of print]

PMID:
30903274
14.

Spotlight on S-ICD™ therapy: 10 years of clinical experience and innovation.

Bögeholz N, Willy K, Niehues P, Rath B, Dechering DG, Frommeyer G, Kochhäuser S, Löher A, Köbe J, Reinke F, Eckardt L.

Europace. 2019 Mar 18. pii: euz029. doi: 10.1093/europace/euz029. [Epub ahead of print]

PMID:
30887039
15.

Inadvertent transseptal puncture into the aortic root: the narrow edge between luck and catastrophe in interventional cardiology.

Chen H, Fink T, Zhan X, Chen M, Eckardt L, Long D, Ma J, Rosso R, Mathew S, Xue Y, Ju W, Wasmer K, Ma C, Yang J, Maurer T, Yang B, Heeger CH, Ho SY, Kuck KH, Wu S, Ouyang F.

Europace. 2019 Mar 18. pii: euz042. doi: 10.1093/europace/euz042. [Epub ahead of print]

PMID:
30887036
16.

Histone deacetylase inhibition by Entinostat for the prevention of electrical and structural remodeling in heart failure.

Freundt JK, Frommeyer G, Spieker T, Wötzel F, Grotthoff JS, Stypmann J, Hempel G, Schäfers M, Jacobs AH, Eckardt L, Lange PS.

BMC Pharmacol Toxicol. 2019 Mar 6;20(1):16. doi: 10.1186/s40360-019-0294-x.

17.

Digitalis therapy is associated with higher comorbidities and poorer prognosis in patients undergoing ablation of atrial arrhythmias: data from the German Ablation Registry.

Frommeyer G, Brachmann J, Ince H, Spitzer SG, Thomas D, Willems S, Schumacher B, Schirdewahn P, Lewalter T, Hochadel M, Senges J, Eckardt L.

Clin Res Cardiol. 2019 Feb 23. doi: 10.1007/s00392-019-01442-w. [Epub ahead of print]

PMID:
30798346
18.

[Premature ventricular contractions and tachycardia in a structurally normal heart : Idiopathic PVC and VT].

Busch S, Eckardt L, Sommer P, Meyer C, Bonnemeier H, Thomas D, Neuberger HR, Tilz RR, Steven D, von Bary C, Kuniss M, Voss F, Estner HL.

Herzschrittmacherther Elektrophysiol. 2019 Jun;30(2):212-224. doi: 10.1007/s00399-019-0607-1. Epub 2019 Feb 14. German.

PMID:
30767064
19.

Postnatal Paraclinical Parameters Associated to Occurrence of Intracerebral Hemorrhage in Preterm Infants.

Lampe R, Turova V, Botkin N, Eckardt L, Felderhoff-Müser U, Rieger-Fackeldey E, Alves-Pinto A, Kovtanyuk A, Sidorenko I.

Neuropediatrics. 2019 Apr;50(2):103-110. doi: 10.1055/s-0038-1677515. Epub 2019 Jan 29.

PMID:
30695800
20.

Can we rely on Danish? Real-world data on patients with nonischemic cardiomyopathy from the German Device Registry.

Frommeyer G, Andresen D, Ince H, Maier S, Stellbrink C, Kleemann T, Seidl K, Hoffmann E, Zrenner B, Hochadel M, Senges J, Eckardt L.

Heart Vessels. 2019 Jul;34(7):1196-1202. doi: 10.1007/s00380-018-01337-2. Epub 2019 Jan 3.

PMID:
30607538
21.

Digitalis Promotes Ventricular Arrhythmias in Flecainide- and Ranolazine-Pretreated Hearts.

Ellermann C, Wolfes J, Puckhaber D, Bögeholz N, Leitz P, Lange PS, Eckardt L, Frommeyer G.

Cardiovasc Toxicol. 2019 Jun;19(3):237-243. doi: 10.1007/s12012-018-9494-7.

PMID:
30515668
22.

Modeling Cerebral Blood Flow Dependence on Carbon Dioxide and Mean Arterial Blood Pressure in the Immature Brain With Accounting for the Germinal Matrix.

Sidorenko I, Turova V, Botkin N, Eckardt L, Alves-Pinto A, Felderhoff-Müser U, Rieger-Fackeldey E, Kovtanyuk A, Lampe R.

Front Neurol. 2018 Oct 9;9:812. doi: 10.3389/fneur.2018.00812. eCollection 2018.

23.

[Subcutaneous implantable cardioverter-defibrillator : Current status and perspectives].

Niehues P, Frommeyer G, Reinke F, Eckardt L.

Herzschrittmacherther Elektrophysiol. 2018 Dec;29(4):349-354. doi: 10.1007/s00399-018-0593-8. Epub 2018 Oct 10. Review. German.

PMID:
30306303
24.

Device updates successfully reduce T‑wave oversensing and inappropriate shocks in subcutaneous ICD patients.

Larbig R, Motloch LJ, Bettin M, Fischer A, Bode N, Frommeyer G, Loeher A, Koebe J, Reinke F, Eckardt L.

Neth Heart J. 2018 Dec;26(12):606-611. doi: 10.1007/s12471-018-1160-y.

25.

Ivabradine Aggravates the Proarrhythmic Risk in Experimental Models of Long QT Syndrome.

Frommeyer G, Weller J, Ellermann C, Leitz P, Kochhäuser S, Lange PS, Dechering DG, Eckardt L.

Cardiovasc Toxicol. 2019 Apr;19(2):129-135. doi: 10.1007/s12012-018-9482-y.

PMID:
30238354
26.

Long-term symptom improvement and patient satisfaction after AV-node ablation vs. pulmonary vein isolation for symptomatic atrial fibrillation: results from the German Ablation Registry.

Wasmer K, Hochadel M, Wieneke H, Spitzer SG, Brachmann J, Straube F, Tebbenjohanns J, Groschup G, Heisel A, Lewalter T, Senges J, Eckardt L.

Clin Res Cardiol. 2019 Apr;108(4):395-401. doi: 10.1007/s00392-018-1368-2. Epub 2018 Sep 7.

PMID:
30194475
27.

Distinct Occurrence of Proarrhythmic Afterdepolarizations in Atrial Versus Ventricular Cardiomyocytes: Implications for Translational Research on Atrial Arrhythmia.

Bögeholz N, Pauls P, Dechering DG, Frommeyer G, Goldhaber JI, Pott C, Eckardt L, Müller FU, Schulte JS.

Front Pharmacol. 2018 Aug 21;9:933. doi: 10.3389/fphar.2018.00933. eCollection 2018.

28.

Remaining challenges in catheter ablation of accessory pathways: rare entity of coronary sinus diverticulum-associated pathways.

Leitz P, Wasmer K, Köbe J, Dechering DG, Frommeyer G, Güner F, Ellermann C, Reinke F, Eckardt L.

Clin Res Cardiol. 2019 Apr;108(4):388-394. doi: 10.1007/s00392-018-1367-3. Epub 2018 Sep 4.

PMID:
30182165
29.

Extended ECG monitoring with an implantable loop recorder in patients with cryptogenic stroke: time schedule, reasons for explantation and incidental findings (results from the TRACK-AF trial).

Bettin M, Dechering D, Kochhäuser S, Bode N, Eckardt L, Frommeyer G, Reinke F.

Clin Res Cardiol. 2019 Mar;108(3):309-314. doi: 10.1007/s00392-018-1358-4. Epub 2018 Aug 22.

PMID:
30167809
30.

Improved risk stratification for patients with atrial fibrillation by advancing the concept of atrial cardiomyopathy?

Bögeholz N, Dechering DG, Eckardt L.

Int J Cardiol. 2018 Dec 1;272:219-220. doi: 10.1016/j.ijcard.2018.08.014. Epub 2018 Aug 11. No abstract available.

PMID:
30121178
31.

Overexpression of the Na+ /Ca2+ exchanger influences ouabain-mediated spontaneous Ca2+ activity but not positive inotropy.

Bögeholz N, Pauls P, Bauer BK, Schulte JS, Frommeyer G, Dechering DG, Boknik P, Kirchhefer U, Müller FU, Pott C, Eckardt L.

Fundam Clin Pharmacol. 2019 Feb;33(1):43-51. doi: 10.1111/fcp.12404. Epub 2018 Aug 30.

PMID:
30092622
32.

[High-resolution 3D mapping : Opportunities and limitations of the Rhythmia™ mapping system].

Ellermann C, Frommeyer G, Eckardt L.

Herzschrittmacherther Elektrophysiol. 2018 Sep;29(3):284-292. doi: 10.1007/s00399-018-0580-0. Epub 2018 Jul 17. Review. German.

PMID:
30019115
33.

The Transcription Factor ATF4 Promotes Expression of Cell Stress Genes and Cardiomyocyte Death in a Cellular Model of Atrial Fibrillation.

Freundt JK, Frommeyer G, Wötzel F, Huge A, Hoffmeier A, Martens S, Eckardt L, Lange PS.

Biomed Res Int. 2018 May 29;2018:3694362. doi: 10.1155/2018/3694362. eCollection 2018.

34.

Ranolazine Prevents Levosimendan-Induced Atrial Fibrillation.

Ellermann C, Kohnke A, Dechering DG, Kochhäuser S, Reinke F, Fehr M, Eckardt L, Frommeyer G.

Pharmacology. 2018;102(3-4):138-141. doi: 10.1159/000490572. Epub 2018 Jul 6.

PMID:
29982246
35.

Prevention of sudden cardiac death in patients with Tetralogy of Fallot: Risk assessment and long term outcome.

Probst J, Diller GP, Reinecke H, Leitz P, Frommeyer G, Orwat S, Vormbrock J, Radke R, de Torres Alba F, Kaleschke G, Baumgartner H, Eckardt L, Wasmer K.

Int J Cardiol. 2018 Oct 15;269:91-96. doi: 10.1016/j.ijcard.2018.06.107. Epub 2018 Jun 28.

PMID:
29980366
36.

Acute electrophysiologic effects of the polyphenols resveratrol and piceatannol in rabbit atria.

Frommeyer G, Wolfes J, Ellermann C, Kochhäuser S, Dechering DG, Eckardt L.

Clin Exp Pharmacol Physiol. 2019 Jan;46(1):94-98. doi: 10.1111/1440-1681.13005.

PMID:
29956844
37.

Follow-up of the first patients with a totally subcutaneous ICD in Germany from implantation till battery depletion.

Bettin M, Rath B, Ellermann C, Leitz P, Reinke F, Köbe J, Eckardt L, Frommeyer G.

Clin Res Cardiol. 2019 Jan;108(1):16-21. doi: 10.1007/s00392-018-1296-1. Epub 2018 Jun 12.

PMID:
29948287
38.

Updated Survey on Interventional Electrophysiology: 5-Year Follow-Up of Infrastructure, Procedures, and Training Positions in Germany.

Eckardt L, Frommeyer G, Sommer P, Steven D, Deneke T, Estner HL, Kriatselis C, Kuniss M, Busch S, Tilz RR, Bonnemeier H, von Bary C, Voss F, Meyer C, Thomas D, Neuberger HR.

JACC Clin Electrophysiol. 2018 Jun;4(6):820-827. doi: 10.1016/j.jacep.2018.01.001. Epub 2018 Mar 1.

39.

PHD2 inactivation in Type I cells drives HIF-2α-dependent multilineage hyperplasia and the formation of paraganglioma-like carotid bodies.

Fielding JW, Hodson EJ, Cheng X, Ferguson DJP, Eckardt L, Adam J, Lip P, Maton-Howarth M, Ratnayaka I, Pugh CW, Buckler KJ, Ratcliffe PJ, Bishop T.

J Physiol. 2018 Jun 19. doi: 10.1113/JP275996. [Epub ahead of print]

40.

Long-term single-center experience of defibrillator therapy in children and adolescents.

Frommeyer G, Feder S, Bettin M, Debus V, Köbe J, Reinke F, Uebing A, Eckardt L, Kehl HG.

Int J Cardiol. 2018 Nov 15;271:105-108. doi: 10.1016/j.ijcard.2018.05.130. Epub 2018 Jun 1.

PMID:
29885825
41.

Direct comparison of the novel automated screening tool (AST) versus the manual screening tool (MST) in patients with already implanted subcutaneous ICD.

Bögeholz N, Pauls P, Güner F, Bode N, Fischer A, Dechering D, Frommeyer G, Köbe J, Wasmer K, Eckardt L, Reinke F.

Int J Cardiol. 2018 Aug 15;265:90-96. doi: 10.1016/j.ijcard.2018.02.030.

PMID:
29885706
42.

Change of sensing vector in the subcutaneous ICD during follow-up and after device replacement.

Bettin M, Rath B, Ellermann C, Leitz P, Bögeholz N, Reinke F, Köbe J, Eckardt L, Frommeyer G.

J Cardiovasc Electrophysiol. 2018 Sep;29(9):1241-1247. doi: 10.1111/jce.13647. Epub 2018 Jun 19.

PMID:
29873873
43.

Long-Term Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Teenagers and Young Adults.

Bettin M, Larbig R, Rath B, Fischer A, Frommeyer G, Reinke F, Köbe J, Eckardt L.

JACC Clin Electrophysiol. 2017 Dec 26;3(13):1499-1506. doi: 10.1016/j.jacep.2017.08.017. Epub 2017 Nov 6.

44.

Application of the Bogossian formula for evaluation of the QT interval in pacemaker patients with stimulated left bundle branch block.

Weipert KF, Bogossian H, Conzen P, Frommeyer G, Gemein C, Helmig I, Chasan R, Eckardt L, Seyfarth M, Lemke B, Zarse M, Hamm CW, Schmitt J, Erkapic D.

Clin Res Cardiol. 2018 Nov;107(11):1033-1039. doi: 10.1007/s00392-018-1275-6. Epub 2018 May 11.

PMID:
29752526
45.

Comparing learning curves of two established "single-shot" devices for ablation of atrial fibrillation.

Leitz P, Mönnig G, Güner F, Dechering DG, Wasmer K, Reinke F, Lange PS, Eckardt L, Frommeyer G.

J Interv Card Electrophysiol. 2018 Dec;53(3):317-322. doi: 10.1007/s10840-018-0361-z. Epub 2018 Apr 20.

PMID:
29679185
46.

Postoperative ergometry-guided programming does not prevent T-wave oversensing and inappropriate shocks in S-ICD patients.

Larbig R, Motloch LJ, Bettin M, Fischer A, Frommeyer G, Reinke F, Loeher A, Eckardt L, Köbe J.

Pacing Clin Electrophysiol. 2018 Jun;41(6):567-571. doi: 10.1111/pace.13327. Epub 2018 Apr 25.

PMID:
29572880
47.

Ablation Outcomes and Predictors of Mortality Following Catheter Ablation for Ventricular Tachycardia: Data From the German Multicenter Ablation Registry.

Tilz RR, Lin T, Eckardt L, Deneke T, Andresen D, Wieneke H, Brachmann J, Kääb S, Chun KRJ, Münkler P, Lewalter T, Hochadel M, Senges J, Kuck KH.

J Am Heart Assoc. 2018 Mar 23;7(6). pii: e007045. doi: 10.1161/JAHA.117.007045.

48.

Outcome of slow pathway modulation for atrioventricular nodal reentrant tachycardia with 50 versus 30 watts-more power, more effect?

Dechering DG, Schleberger R, Greiser E, Dickow J, Koebe J, Frommeyer G, Willems S, Eckardt L, Hoffmann BA, Wasmer K.

J Interv Card Electrophysiol. 2018 Jul;52(2):157-161. doi: 10.1007/s10840-018-0360-0. Epub 2018 Mar 19.

PMID:
29556909
49.

Monitoring the decay of the current of injury (COI): A re-visited parameter to predict performance of transvenous pacemaker leads.

Bögeholz N, Reinke F, Eckardt L.

Int J Cardiol. 2018 May 1;258:157-158. doi: 10.1016/j.ijcard.2018.01.126. No abstract available.

PMID:
29544923
50.

[Management of inappropriate shocks/T-wave-oversensing in S-ICD®-patients].

Larbig R, Bettin M, Motloch LJ, Fischer A, Bode N, Frommeyer G, Reinke F, Loeher A, Eckardt L, Köbe J.

Herzschrittmacherther Elektrophysiol. 2018 Mar;29(1):122-126. doi: 10.1007/s00399-018-0555-1. Epub 2018 Feb 12. Review. German.

PMID:
29435656

Supplemental Content

Loading ...
Support Center